Currently, there are very few treatment options for those with Alzheimer’s disease (AD). Clinical trials are the only way for new treatments to be developed that can prevent progression of the disease. Clinical trials also help us learn more about AD. At the Byrd Institute, we are involved in several research studies, adding new studies regularly. We offer a range of participation options including prevention studies for older people without memory loss and studies that include treatment of mild cognitive impairment (MCI) and mild to moderate AD. Some of our trials are observation-only, while others involve oral medications, injections, or infusions. Additionally, many trials include special blood tests, cognitive testing, and brain imaging (MRIs and PET scans). Below is a list of our current study opportunities.

For Individuals with Memory Loss

.

• A 33-week trial investigating an oral treatment which may improve cognition and function in patients with Alzheimer’s disease. This study is for patients 60-85 years old with mild to moderate Alzheimer’s disease.

For Individuals without Memory Loss

• Check back often for new trials.

For Individuals with Memory Loss

• Check back often for new trials.

For Individuals without Memory Loss

• Check back often for new trials.

Join Our Newsletter

Whether you are a healthcare provider, caregiver, patient, or advocate, our goal is to keep you informed of our research efforts, community events, and Alzheimer's related news. Our newsletter is distributed every three months.  Visit the link to subscribe.  Byrd Alzheimer's Institute Clinical Trials

We always have new trials just around the corner. Please check back with us for updates!

For more information about our clinical research, contact:

Jenny Echevarria
jenny8@usf.edu
(813) 396-9695 

Anna Sladky 
asladky@usf.edu
(813) 974-4904